Author: Nicholas Alan Clayton

SPAC-morning-roundup
SPAC-morning-roundup
SPAC-morning-roundup
new-spac
SPAC-morning-roundup
SPAC-morning-roundup
china pic
Teaser

APx Acquisition Corp. I (APXI) Signs LOI with DNA Test Firm

APx Acquisition Corp. (NASDAQ:APXI) announced a letter of intent to combine with an unnamed biotech firm, but teased little other information as it heads into an extension vote on Friday.

Shareholders at the meeting are to decide whether to give APx the ability to extend its transaction deadline to a maximum of December 9, 2024 in exchange for monthly contributions of the lesser of $125,000 or $0.025 per share monthly. ...READ MORE

SPAC-morning-roundup
SPAC-morning-roundup
lock-ups

10X Capital Venture II (VCXA) Tweaks African Agriculture Terms, Funding Ahead of Vote

10x Capital Venture II (NASDAQ:VCXA) filed a variety of changes to its combination with African Agriculture while also postponing its completion vote to 8 am ET December 5.

The tweaks waive African Agriculture’s requirement to secure an offtake agreement and also shift 3,000,000 shares to a bonus pool for all combined company shareholders. ...READ MORE

SPAC-morning-roundup
SPAC-morning-roundup
SPAC-morning-roundup